Your browser doesn't support javascript.
loading
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial.
Bernard-Tessier, Alice; Jeannot, Emmanuelle; Guenat, David; Debernardi, Alice; Michel, Marc; Proudhon, Charlotte; Vincent-Salomon, Anne; Bièche, Ivan; Pierga, Jean-Yves; Buecher, Bruno; Meurisse, Aurélia; François, Éric; Cohen, Romain; Jary, Marine; Vendrely, Véronique; Samalin, Emmanuelle; El Hajbi, Farid; Baba-Hamed, Nabil; Borg, Christophe; Bidard, François-Clément; Kim, Stefano.
Affiliation
  • Bernard-Tessier A; Department of Biopathology and Genetics, Institut Curie, PSL Research University, Paris and Saint-Cloud, France.
  • Jeannot E; Department of Biopathology and Genetics, Institut Curie, PSL Research University, Paris and Saint-Cloud, France.
  • Guenat D; Centre National de Référence Papillomavirus, Centre Hospitalier Universitaire de Besançon, Besançon, France.
  • Debernardi A; EA3181, Université Bourgogne Franche-Comté, LabEx LipSTIC ANR-11-LABX-0021, Besançon, France.
  • Michel M; EA3181, Université Bourgogne Franche-Comté, LabEx LipSTIC ANR-11-LABX-0021, Besançon, France. alice.bernard@curie.fr fcbidard@curie.fr.
  • Proudhon C; Circulating Tumor Biomarkers Laboratory, Institut Curie, PSL Research University, Paris, France.
  • Vincent-Salomon A; Circulating Tumor Biomarkers Laboratory, Institut Curie, PSL Research University, Paris, France.
  • Bièche I; Department of Biopathology and Genetics, Institut Curie, PSL Research University, Paris and Saint-Cloud, France.
  • Pierga JY; Department of Biopathology and Genetics, Institut Curie, PSL Research University, Paris and Saint-Cloud, France.
  • Buecher B; Université Paris Descartes, Paris, France.
  • Meurisse A; Circulating Tumor Biomarkers Laboratory, Institut Curie, PSL Research University, Paris, France.
  • François É; Université Paris Descartes, Paris, France.
  • Cohen R; Department of Medical Oncology, Institut Curie, PSL Research University, Paris and Saint-Cloud, France.
  • Jary M; Department of Medical Oncology, Institut Curie, PSL Research University, Paris and Saint-Cloud, France.
  • Vendrely V; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR) Oncology Multidisciplinary Group, Paris, France.
  • Samalin E; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.
  • El Hajbi F; Department of Medical Oncology, Centre Antoine-Lacassagne, Nice, France.
  • Baba-Hamed N; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR) Oncology Multidisciplinary Group, Paris, France.
  • Borg C; Sorbonne Université, Department of Medical Oncology, AP-HP, Hôpital Saint-Antoine, F-75012 Paris, France.
  • Bidard FC; Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon, Besançon, France.
  • Kim S; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France.
Clin Cancer Res ; 25(7): 2109-2115, 2019 Apr 01.
Article in En | MEDLINE | ID: mdl-30504426
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / Papillomavirus Infections / Circulating Tumor DNA Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / Papillomavirus Infections / Circulating Tumor DNA Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: France